129 related articles for article (PubMed ID: 16398405)
1. Pancreatic cancer cells invasiveness is mainly affected by interleukin-1beta not by transforming growth factor-beta1.
Greco E; Basso D; Fogar P; Mazza S; Navaglia F; Zambon CF; Falda A; Pedrazzoli S; Ancona E; Plebani M
Int J Biol Markers; 2005; 20(4):235-41. PubMed ID: 16398405
[TBL] [Abstract][Full Text] [Related]
2. Cytokines modulate MIA PaCa 2 and CAPAN-1 adhesion to extracellular matrix proteins.
Stefani AL; Basso D; Panozzo MP; Greco E; Mazza S; Zancanaro F; De Franchis G; Plebani M
Pancreas; 1999 Nov; 19(4):362-9. PubMed ID: 10547196
[TBL] [Abstract][Full Text] [Related]
3. Modulation of ezrin and E-cadherin expression by IL-1beta and TGF-beta1 in human trophoblasts.
Karmakar S; Das C
J Reprod Immunol; 2004 Dec; 64(1-2):9-29. PubMed ID: 15596224
[TBL] [Abstract][Full Text] [Related]
4. Protein-bound polysaccharide PSK inhibits tumor invasiveness by down-regulation of TGF-beta1 and MMPs.
Zhang H; Morisaki T; Matsunaga H; Sato N; Uchiyama A; Hashizume K; Nagumo F; Tadano J; Katano M
Clin Exp Metastasis; 2000; 18(4):343-52. PubMed ID: 11448066
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation.
Ellenrieder V; Hendler SF; Boeck W; Seufferlein T; Menke A; Ruhland C; Adler G; Gress TM
Cancer Res; 2001 May; 61(10):4222-8. PubMed ID: 11358848
[TBL] [Abstract][Full Text] [Related]
6. Inhibition and mechanism of action of a protease inhibitor in human pancreatic cancer cells.
Uchima Y; Sawada T; Nishihara T; Maeda K; Ohira M; Hirakawa K
Pancreas; 2004 Aug; 29(2):123-31. PubMed ID: 15257104
[TBL] [Abstract][Full Text] [Related]
7. Lipoxin A4 reverses mesenchymal phenotypes to attenuate invasion and metastasis via the inhibition of autocrine TGF-β1 signaling in pancreatic cancer.
Zong L; Chen K; Jiang Z; Chen X; Sun L; Ma J; Zhou C; Xu Q; Duan W; Han L; Lei J; Li X; Ma Q; Wang Z
J Exp Clin Cancer Res; 2017 Dec; 36(1):181. PubMed ID: 29228980
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta1 acts as a potent inhibitor of complement C3 biosynthesis in human pancreatic cancer cell lines.
Andoh A; Shimada M; Takaya H; Hata K; Fujiyama Y; Bamba T
Pancreas; 2000 Mar; 20(2):138-45. PubMed ID: 10707928
[TBL] [Abstract][Full Text] [Related]
9. Activation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
Mol Cancer; 2005 Oct; 4():37. PubMed ID: 16209712
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta 1 is a negative regulator for differentiated thyroid cancer: studies of growth, migration, invasion, and adhesion of cultured follicular and papillary thyroid cancer cell lines.
Hölting T; Zielke A; Siperstein AE; Clark OH; Duh QY
J Clin Endocrinol Metab; 1994 Sep; 79(3):806-13. PubMed ID: 8077365
[TBL] [Abstract][Full Text] [Related]
11. [Effects of colchicine on synthesis and excretion of cytokines and extracellular matrix by human renal fibroblasts].
Huang WY; Sun H; Pan XQ; Fei L; Guo M; Bao HY; Chen RH; Jiang XY
Zhonghua Er Ke Za Zhi; 2004 Jul; 42(7):524-8. PubMed ID: 15324573
[TBL] [Abstract][Full Text] [Related]
12. Rhodostomin inhibits the transforming growth factor-beta1-enhanced adhesion activity of ROS 17/2.8 osteosarcoma cells.
Yang RS; Huang TF
Tohoku J Exp Med; 2000 Jul; 191(3):145-55. PubMed ID: 10997555
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta-induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system.
Ellenrieder V; Hendler SF; Ruhland C; Boeck W; Adler G; Gress TM
Int J Cancer; 2001 Jul; 93(2):204-11. PubMed ID: 11410867
[TBL] [Abstract][Full Text] [Related]
14. TGF-β1 increases invasiveness of SW1990 cells through Rac1/ROS/NF-κB/IL-6/MMP-2.
Binker MG; Binker-Cosen AA; Gaisano HY; de Cosen RH; Cosen-Binker LI
Biochem Biophys Res Commun; 2011 Feb; 405(1):140-5. PubMed ID: 21219858
[TBL] [Abstract][Full Text] [Related]
15. Stimulation and inhibition of uveal melanoma invasion by HGF, GRO, IL-1alpha and TGF-beta.
Woodward JK; Elshaw SR; Murray AK; Nichols CE; Cross N; Laws D; Rennie IG; Sisley K
Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3144-52. PubMed ID: 12356817
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor mediates detachment from and invasion through collagen I and Matrigel in Capan-1 pancreatic cancer cells.
Shirk AJ; Kuver R
BMC Gastroenterol; 2005 Mar; 5():12. PubMed ID: 15801978
[TBL] [Abstract][Full Text] [Related]
17. TGF-β1 regulates the invasive and metastatic potential of mucoepidermoid carcinoma cells.
Wang J; Chen J; Zhang K; Zhao Y; Nör JE; Wu J
J Oral Pathol Med; 2011 Nov; 40(10):762-8. PubMed ID: 21689159
[TBL] [Abstract][Full Text] [Related]
18. Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells.
Festuccia C; Angelucci A; Gravina GL; Villanova I; Teti A; Albini A; Bologna M
Int J Cancer; 2000 Feb; 85(3):407-15. PubMed ID: 10652434
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of integrins by interleukin-1alpha, and their relationship with metastatic and invasive behavior of human pancreatic ductal adenocarcinoma cells.
Sawai H; Takeyama H; Yamamoto M; Furuta A; Funahashi H; Okada Y; Sato M; Tanaka M; Manabe T
J Surg Oncol; 2003 Jan; 82(1):51-6. PubMed ID: 12501168
[TBL] [Abstract][Full Text] [Related]
20. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
